Oksana Simonova

Oksana Simonova is a partner in the Kyiv office of Baker McKenzie with over 12 years of experience in advising clients on a wide range of sophisticated cross-border transactions. In 2012, she was appointed to lead the Kyiv office’s Competition and Pharmaceuticals practice groups. Ms. Simonova advises international clients on Ukrainian merger control and competition law issues (including in the pharmaceuticals industry). She also has broad experience in various corporate finance transactions (including syndicated lending, Eurobonds and IPOs). She has worked on numerous international capital markets offerings from Ukraine and led the local legal team on the first main market London Stock Exchange listing of a mining company from Ukraine. Her practice also includes mergers and acquisitions, and general corporate and commercial law matters.

In brief At the end of March, the Antimonopoly Committee of Ukraine (“AMC”) published its Annual Report for 2022 (“Report”). The full-scale russian invasion caused significant damage to Ukraine’s economy. Thus, in 2022, the AMC focused on markets that are strategically important for the country, including the markets for: (i) electricity, (ii) natural gas, (iii) light oil products, (iv) housing and communal services, (v) construction materials (i.e., cement), (vi) medicines, (vii) real estate, (viii) information…